| |
| 2008 | ||
|---|---|---|
| 1 | EE | Anatoly L. Mayburd, Inna Golovchikova, James L. Mulshine: Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets. Bioinformatics 24(3): 389-395 (2008) |
| 1 | Inna Golovchikova | [1] |
| 2 | James L. Mulshine | [1] |